Vascular News and Research

RSS

Meriter to join Wisconsin Heart & Vascular Institute

Effective January 1, 2012, Wisconsin Heart & Vascular Institute will join Meriter Medical Group. The practice, which includes 16 cardiologists, vascular surgeons and mid-level providers who are highly trained specialists with experience in all areas of cardiovascular care, will be renamed Meriter Wisconsin Heart. Meriter Medical Group will thus have grown from 68 providers to 116 in less than 2 years, an increase of 71%.

29 Oct 2011

Cardiovascular Associates reaches definitive agreement with ABHS

Cardiovascular Associates (CVA), one of the leading cardiovascular care practices, and Alexian Brothers Health System (ABHS) have reached a definitive agreement to formally align the two prestigious organizations. The agreement will form the Alexian Brothers Heart and Vascular Institute and provide the framework that will continue to grow ABHS's reputation as a center of cardiac care excellence and innovation.

29 Oct 2011

Potential avenue to make an unhealthy heart grow more like a healthy version

Identification of three fatty acids involved in the extreme growth of Burmese pythons' hearts following large meals could prove beneficial in treating diseased human hearts, according to research co-authored by a University of Alabama scientist and publishing in the Oct. 28 issue of Science.

28 Oct 2011

Platform approach to chemically incorporate homing receptors onto surface of cells

Stem cell therapies hold enormous potential to address some of the most tragic illnesses, diseases, and tissue defects world-wide. However, the inability to target cells to tissues of interest poses a significant barrier to effective cell therapy.

28 Oct 2011

Special hospital team reduces cumulated risk of stroke in TIA patients

28 Oct 2011

Special team care reduces cumulated stroke risk after transient ischaemic attacks

Patients who had a transient ischaemic attack (TIA), sometimes referred to as a "mini stroke", were much less likely to experience further vascular events in the first year if their care was co-ordinated by a special hospital team. That is the key finding from a study published in the November issue of the European Journal of Neurology.

28 Oct 2011

Million Hearts' goal to prevent a million heart attacks and strokes in five years

In the time needed to read out loud the headline on this story, someone has died from a stroke. Every 6 seconds, someone in the world dies from stroke. The Centers for Disease Control and Prevention, in support of World Stroke Day, Oct. 29, 2011, asks Americans to take immediate action to reduce their risk for stroke.

28 Oct 2011

Medtronic initiates Symplicity System clinical study in treatment-resistant hypertension

Medtronic Inc. announced today the start of SYMPLICITY HTN-3, the company's U.S. clinical trial of the Symplicity Renal Denervation System for treatment-resistant hypertension.

From Medtronic 27 Oct 2011

Largest study on diabetes and foot ulcers

What's crucial for a diabetic's foot sore to heal is that the ulcer is superficial, blood circulation is normal, and the person has had diabetes for short time. This is shown in the world's largest diabetes study regarding foot ulcers, which has been carried out by the researcher Magdalena Annersten Gerhater at Malmö University in Sweden.

27 Oct 2011

Simple blood test could quantify a smoker's lung toxicity and danger of heart disease

A simple blood test could someday quantify a smoker's lung toxicity and danger of heart disease, researchers at UT Southwestern Medical Center have found.

27 Oct 2011

Less invasive anesthetic techniques may limit postoperative complications in EVAR patients

A new study indicates that using less invasive spinal, epidural and local/monitored anesthesia care (MAC) is better than general anesthesia for elective endovascular repair of infrarenal abdominal aortic aneurysms (EVAR).

24 Oct 2011

Macular degeneration drug may cause increased IOP

Two major drug trials conclude there was little risk from a drug aimed at age-related macular degeneration. Yet a Mayo Clinic ophthalmologist began to note something concerning in some of her patients: an increase in pressure inside the eye. It led to a retrospective study and findings that will be presented at the American Academy of Ophthalmology in Orlando.

24 Oct 2011

CryoLife begins enrollment in BioFoam Surgical Matrix IDE clinical trial

CryoLife, Inc.,, a leading tissue processing and medical device Company focused on cardiac and vascular surgery, today announced that it has enrolled the first patient in its U.S. Investigational Device Exemption (IDE) clinical trial for its BioFoam® Surgical Matrix protein hydrogel technology. In connection with the trial, BioFoam will be used as an adjunct to conservative measures of achieving hemostasis on newly resected liver parenchyma.

24 Oct 2011

Teleflex launches ArrowADVANTAGE pressure-injectable peripherally inserted central catheter

Teleflex Incorporated today announced the launch of the ArrowADVANTAGE pressure-injectable peripherally inserted central catheter.

24 Oct 2011

Mesoblast cleared to begin first phase 2 clinical trial for wet AMD

Regenerative medicine company Mesoblast Limited (ASX: MSB) today announced that it has received regulatory clearance from the Singapore Health Sciences Authority (HSA) to commence the first Phase 2 trial of its proprietary allogeneic (off-the-shelf) adult stem cell therapy for patients with proliferation of leaky blood vessels in the eyes – neovascular (“wet”) Age-related Macular Degeneration (AMD).

24 Oct 2011

Mesoblast receives Singapore HSA regulatory clearance to begin wet AMD Phase 2 trial

Regenerative medicine company Mesoblast Limited today announced that it has received regulatory clearance from the Singapore Health Sciences Authority (HSA) to commence the first Phase 2 trial of its proprietary allogeneic (off-the-shelf) adult stem cell therapy for patients with proliferation of leaky blood vessels in the eyes – neovascular Age-related Macular Degeneration.

24 Oct 2011

Mirna, Silence enter agreement to assess delivery systems for novel microRNAs

Silence Therapeutics plc, a leading RNA interference (RNAi) therapeutics company, today announced that it has entered into an agreement with Mirna Therapeutics Inc., a biopharmaceutical company pioneering microRNA-based therapeutics for cancer, to assess the delivery capabilities of Silence's proprietary AtuPLEX and DBTC delivery systems for Mirna's novel microRNAs.

24 Oct 2011

Simulation improves cardiac surgical training results

Residents in cardiac surgery who receive extra training on a take-home simulator do a better job once they get into the operating room, Dr. Buu-Khanh Lam today told the Canadian Cardiovascular Congress 2011, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.

24 Oct 2011

New mathematical models can predict prostate cancer aggressiveness

Alexander R. A. Anderson, Ph.D., co-director of Integrative Mathematical Oncology (IMO) at Moffitt Cancer Center, and his colleagues, Simon Hayward, Ph.D., at Vanderbilt University and Gustavo Ayala, M.D., at Baylor College of Medicine, have received a five-year, $3 million grant from the National Institutes of Health to create new mathematical models to predict prostate cancer aggressiveness.

22 Oct 2011

Bayshore implements number of initiatives after merger with Meridian Health

Last fall Bayshore Community Hospital became the sixth hospital in Meridian's Monmouth and Ocean county system. With a strong focus on customer service, alignment with Meridian Health clinical best practices, a new leadership team, and countless new physicians, Bayshore has begun to develop an exciting plan to create a destination hospital that will become the pride of the community.

21 Oct 2011

Vascular News and Research

Meriter to join Wisconsin Heart & Vascular Institute

Cardiovascular Associates reaches definitive agreement with ABHS

Potential avenue to make an unhealthy heart grow more like a healthy version

Platform approach to chemically incorporate homing receptors onto surface of cells

Special hospital team reduces cumulated risk of stroke in TIA patients

Special team care reduces cumulated stroke risk after transient ischaemic attacks

Million Hearts' goal to prevent a million heart attacks and strokes in five years

Medtronic initiates Symplicity System clinical study in treatment-resistant hypertension

Largest study on diabetes and foot ulcers

Simple blood test could quantify a smoker's lung toxicity and danger of heart disease

Less invasive anesthetic techniques may limit postoperative complications in EVAR patients

Macular degeneration drug may cause increased IOP

CryoLife begins enrollment in BioFoam Surgical Matrix IDE clinical trial

Teleflex launches ArrowADVANTAGE pressure-injectable peripherally inserted central catheter

Mesoblast cleared to begin first phase 2 clinical trial for wet AMD

Mesoblast receives Singapore HSA regulatory clearance to begin wet AMD Phase 2 trial

Mirna, Silence enter agreement to assess delivery systems for novel microRNAs

Simulation improves cardiac surgical training results

New mathematical models can predict prostate cancer aggressiveness

Bayshore implements number of initiatives after merger with Meridian Health

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News